This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
Made some changes to the intro. The extensive detail on systolic heart failure, while enlightening, is not necessary here and should be left to that subject's page. Also there are unsubstantiated claims, such as how inotropes are palliative and not curative (not even sure what that means in this context, or how omecamtiv is curative, which this claim implies), that omecamtiv offers a long term solution, and that heart failure is malignant. Also, omecamtiv mecarbil is not a brand name and thus shouldn't be capitalized. — Preceding unsigned comment added by 126.96.36.199 (talk) 17:50, 3 November 2015 (UTC)